Drug name: Cerebrolysin

Therapeutic effects:

Cerebrolysin improves efficiency of aerobic energy metabolism of the brain, improves intracellular protein synthesis in the developing and aging brain.

As a neuroprotector, Cerebrolysin protects neurons from the damaging effect of lactic acidosis, prevents the formation of free radicals, improves survival and prevents neuronal death in hypoxia and ischemia, reduces the damaging neurotoxic effects of excitatory amino acids (glutamate).

Cerebrolysin is the only peptidergic nootropic drug with proven neurotrophic activity similar to the action of natural factors of neuronal growth (NGF), but manifested in conditions of peripheral administration.

Also, Cerebrolysin has a positive effect in cognitive disorders, the processes of storing and reproducing information, activates mental activity, improves mood, promotes formation of positive emotions, thus having a simulating effect on behavior.

Indications:

• Alzheimer's disease
• dementia of various origins
• ischemic stroke
• traumatic injury of the brain and spinal cord
• chronic cerebrovascular pathology
• mental retardation in children, disorders associated with attention deficit in children

endogenous depression resistant to antidepressants

Side-effects:

In increased individual sensitivity, fast intravenous infusion of Cerebrolysin may cause a slight increase in the body temperature.

Drug interactions:

Cerebrolysin may affect the action of the following groups of drugs:

• antidepressants

MAO inhibitors

Cautions and restrictions:

Cerebrolysin must be avoided in the following conditions:

• intolerance to the drug
• acute renal failure
• status epilepticus

Cerebrolysin should be used with caution in I trimester of pregnancy, allergic diathesis, large seizures.

Additional information:

Store Cerebrolysin in a dark place, of the reach of children, at temperature below 25 ° C. Shelf-life of bottles is 4 years. Shelf-life of vials is 5 years.